drugset / Trial / NCT01138150
Ictal and Interictal Inflammatory Markers in Migraine
Phase 4
Completed
36 enrolled
Johns Hopkins University
The Cleveland Clinic · collabUniversity of Toledo Health Science Campus · collab
RandomizedParallel-groupTriple-blind
Summary
The purpose of this study is to evaluate blood levels of several proteins that may be altered in the inflammation associated with migraine headaches. These blood levels will be evaluated in individuals during an acute migraine attack and compared to their levels when pain free. The investigators study hypothesis is that the pro inflammatory proteins in the blood will be greater than the levels of these proteins when evaluated during a pain free period.
Timeline
- Start
- 2009-09
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | 500 mg | — |
| Comparator | Sumatriptan | Unknown | 85 mg | — |